FATE FY 2017 Earnings — Fate Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FATEFate Therapeutics, Inc.

$142M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-6.7% YoY

Gross Profit

-$30M-736.8% margin

Operating Income

-$42M-1025.9% margin

Net Income

-$43M-1046.1% margin

EPS (Diluted)

$-1.02

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$39M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$105M

Total Liabilities

$28M

Stockholders' Equity

$77M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-6.7%
Gross Profit	-$30M	-$22M	-37.2%
Operating Income	-$42M	-$32M	-31.8%
Net Income	-$43M	-$33M	-28.4%